Details about Darius Lakdawalla
Access statistics for papers by Darius Lakdawalla.
Last updated 2025-01-06. Update your information in the RePEc Author Service.
Short-id: pla295
Jump to Journal Articles Chapters
Working Papers
2025
- The Effect of US COVID-19 Excess Mortality on Social Security Outlays
NBER Working Papers, National Bureau of Economic Research, Inc
2023
- Risk Preferences Over Health: Empirical Estimates and Implications for Healthcare Decision-Making
NBER Working Papers, National Bureau of Economic Research, Inc
2022
- Vaccine Allocation Priorities Using Disease Surveillance and Economic Data
NBER Working Papers, National Bureau of Economic Research, Inc
2019
- Does Medicare Coverage Improve Cancer Detection and Mortality Outcomes?
NBER Working Papers, National Bureau of Economic Research, Inc 
Also in Working Papers, Human Capital and Economic Opportunity Working Group (2019) View citations (1)
See also Journal Article Does Medicare Coverage Improve Cancer Detection and Mortality Outcomes?, Journal of Policy Analysis and Management, John Wiley & Sons, Ltd. (2020) View citations (2) (2020)
- Evaluation of Medical Technologies with Uncertain Benefits
NBER Working Papers, National Bureau of Economic Research, Inc View citations (1)
2018
- Effects of Expanding Health Screening on Treatment - What Should We Expect? What Can We Learn?
NBER Working Papers, National Bureau of Economic Research, Inc View citations (4)
- Effects of expanding health screening on treatment – What should we expect? What can we learn?
Working Papers, Human Capital and Economic Opportunity Working Group View citations (3)
- Mortality Risk, Insurance, and the Value of Life
NBER Working Papers, National Bureau of Economic Research, Inc View citations (4)
2016
- Healing the Poor: The Influence of Patient Socioeconomic Status on Physician Supply Responses
NBER Working Papers, National Bureau of Economic Research, Inc 
See also Journal Article Healing the poor: The influence of patient socioeconomic status on physician supply responses, Journal of Health Economics, Elsevier (2019) View citations (6) (2019)
2015
- Prescription Drug Advertising and Drug Utilization: The Role of Medicare Part D
NBER Working Papers, National Bureau of Economic Research, Inc View citations (10)
See also Journal Article Prescription drug advertising and drug utilization: The role of Medicare Part D, Journal of Public Economics, Elsevier (2023) View citations (1) (2023)
- The Insurance Value of Medical Innovation
NBER Working Papers, National Bureau of Economic Research, Inc View citations (6)
See also Journal Article The insurance value of medical innovation, Journal of Public Economics, Elsevier (2017) View citations (14) (2017)
2014
- Unintended Consequences of Products Liability: Evidence from the Pharmaceutical Market
NBER Working Papers, National Bureau of Economic Research, Inc View citations (3)
See also Journal Article Unintended Consequences of Products Liability: Evidence from the Pharmaceutical Market*, The Journal of Law, Economics, and Organization, Oxford University Press (2020) View citations (3) (2020)
2011
- Economic Instruments for Obesity Prevention: Results of a Scoping Review and Modified Delphi Survey
Monash Economics Working Papers, Monash University, Department of Economics View citations (3)
- Insurers’ Negotiating Leverage and the External Effects of Medicare Part D
Boston University - Department of Economics - Working Papers Series, Boston University - Department of Economics
Also in NBER Working Papers, National Bureau of Economic Research, Inc (2010) View citations (11)
See also Journal Article Insurers’ Negotiating Leverage and the External Effects of Medicare Part D, The Review of Economics and Statistics, MIT Press (2015) View citations (13) (2015)
- The Value of Medican and Pharmaceutical Interventions for Reducing Obesity
Cahiers de recherche, CIRPEE 
See also Journal Article The value of medical and pharmaceutical interventions for reducing obesity, Journal of Health Economics, Elsevier (2012) View citations (8) (2012)
2010
- Health and Access Effects of New Drugs: Combining Experimental and Non-Experimental Data
Cahiers de recherche, CIRPEE
2009
- An Economic Evaluation of the War on Cancer
NBER Working Papers, National Bureau of Economic Research, Inc View citations (5)
See also Journal Article An economic evaluation of the war on cancer, Journal of Health Economics, Elsevier (2010) View citations (23) (2010)
- Food Prices and the Dynamics of Body Weight
NBER Working Papers, National Bureau of Economic Research, Inc View citations (30)
See also Chapter Food Prices and the Dynamics of Body Weight, NBER Chapters, National Bureau of Economic Research, Inc (2011) View citations (15) (2011)
- Insurer Bargaining and Negotiated Drug Prices in Medicare Part D
NBER Working Papers, National Bureau of Economic Research, Inc View citations (4)
- International Differences in Longevity and Health and Their Economic Consequences
IZA Discussion Papers, Institute of Labor Economics (IZA) View citations (1)
Also in NBER Working Papers, National Bureau of Economic Research, Inc (2009) View citations (1) Social and Economic Dimensions of an Aging Population Research Papers, McMaster University (2009) View citations (1)
- The Welfare Effects of Medical Malpractice Liability
NBER Working Papers, National Bureau of Economic Research, Inc View citations (7)
See also Journal Article The welfare effects of medical malpractice liability, International Review of Law and Economics, Elsevier (2012) View citations (14) (2012)
- Understanding the Economic Consequences of Shifting Trends in Population Health
NBER Working Papers, National Bureau of Economic Research, Inc View citations (7)
Also in IZA Discussion Papers, Institute of Labor Economics (IZA) (2009) View citations (6) Social and Economic Dimensions of an Aging Population Research Papers, McMaster University (2009) View citations (7)
2007
- Intellectual Property and Marketing
Working Papers, The University of Chicago Booth School of Business, George J. Stigler Center for the Study of the Economy and the State 
Also in NBER Working Papers, National Bureau of Economic Research, Inc (2006) View citations (10)
- The Welfare Effects of Public Drug Insurance
NBER Working Papers, National Bureau of Economic Research, Inc View citations (20)
2006
- Catastrophe Bonds, Reinsurance, and the Optimal Collateralization of Risk-Transfer
NBER Working Papers, National Bureau of Economic Research, Inc View citations (11)
See also Journal Article Catastrophe Bonds, Reinsurance, and the Optimal Collateralization of Risk Transfer, Journal of Risk & Insurance, The American Risk and Insurance Association (2012) View citations (20) (2012)
- Health Insurance as a Two-Part Pricing Contract
NBER Working Papers, National Bureau of Economic Research, Inc View citations (15)
See also Journal Article Health insurance as a two-part pricing contract, Journal of Public Economics, Elsevier (2013) View citations (36) (2013)
- Optimal Liability for Terrorism
NBER Working Papers, National Bureau of Economic Research, Inc
2005
- Insurance and Innovation in Health Care Markets
NBER Working Papers, National Bureau of Economic Research, Inc View citations (6)
2004
- HIV Breakthroughs and Risk Sexual Behavior
NBER Working Papers, National Bureau of Economic Research, Inc View citations (17)
See also Journal Article HIV Breakthroughs and Risky Sexual Behavior, The Quarterly Journal of Economics, President and Fellows of Harvard College (2006) View citations (65) (2006)
- Time-Inconsistency and Welfare
NBER Working Papers, National Bureau of Economic Research, Inc View citations (21)
2002
- Does Medicare Benefit the Poor? New Answers to an Old Question
NBER Working Papers, National Bureau of Economic Research, Inc View citations (3)
- Insurance, Self-Protection, and the Economics of Terrorism
NBER Working Papers, National Bureau of Economic Research, Inc View citations (8)
See also Journal Article Insurance, self-protection, and the economics of terrorism, Journal of Public Economics, Elsevier (2005) View citations (34) (2005)
- The Growth of Obesity and Technological Change: A Theoretical and Empirical Examination
Working Papers, The University of Chicago Booth School of Business, George J. Stigler Center for the Study of the Economy and the State View citations (2)
Also in Working Papers, Harris School of Public Policy Studies, University of Chicago (2002)  NBER Working Papers, National Bureau of Economic Research, Inc (2002) View citations (248)
2001
- Are the Young Becoming More Disabled?
NBER Working Papers, National Bureau of Economic Research, Inc View citations (30)
- The Declining Quality of Teachers
NBER Working Papers, National Bureau of Economic Research, Inc View citations (18)
- Understanding Health Disparities Across Education Groups
NBER Working Papers, National Bureau of Economic Research, Inc View citations (23)
1999
- Aging and the Growth of Long-Term Care
Working Papers, Harris School of Public Policy Studies, University of Chicago 
Also in NBER Working Papers, National Bureau of Economic Research, Inc (1999) View citations (7)
1998
- Nonprofit Production and Competition
NBER Working Papers, National Bureau of Economic Research, Inc View citations (44)
- The Rise in Old Age Longevity and the Market for Long-Term Care
Working Papers, The University of Chicago Booth School of Business, George J. Stigler Center for the Study of the Economy and the State 
Also in NBER Working Papers, National Bureau of Economic Research, Inc (1998) View citations (5)
See also Journal Article The Rise in Old-Age Longevity and the Market for Long-Term Care, American Economic Review, American Economic Association (2002) View citations (52) (2002)
Undated
- Nonprofit Production
University of Chicago - Population Research Center, Chicago - Population Research Center View citations (7)
Journal Articles
2024
- A principled approach to non-discrimination in cost-effectiveness
The European Journal of Health Economics, 2024, 25, (8), 1393-1416 View citations (1)
- Risk preferences over health: Empirical estimates and implications for medical decision-making
Journal of Health Economics, 2024, 94, (C) View citations (1)
- Valuing the Societal Impact of Medicines and Other Health Technologies: A User Guide to Current Best Practices
Forum for Health Economics & Policy, 2024, 27, (1), 29-116
2023
- Prescription drug advertising and drug utilization: The role of Medicare Part D
Journal of Public Economics, 2023, 221, (C) View citations (1)
See also Working Paper Prescription Drug Advertising and Drug Utilization: The Role of Medicare Part D, NBER Working Papers (2015) View citations (10) (2015)
- The Generalized Risk-Adjusted Cost-Effectiveness (GRACE) Model for Measuring the Value of Gains in Health: An Exact Formulation
Journal of Benefit-Cost Analysis, 2023, 14, (1), 44-67 View citations (2)
2022
- A guide to extending and implementing generalized risk-adjusted cost-effectiveness (GRACE)
The European Journal of Health Economics, 2022, 23, (3), 433-451 View citations (1)
2021
- Predicting quantity and quality of life with the Future Elderly Model
Health Economics, 2021, 30, (S1), 52-79 View citations (3)
- The economics of alternative payment models for pharmaceuticals
The European Journal of Health Economics, 2021, 22, (4), 559-569 View citations (4)
2020
- Does Medicare Coverage Improve Cancer Detection and Mortality Outcomes?
Journal of Policy Analysis and Management, 2020, 39, (3), 577-604 View citations (2)
See also Working Paper Does Medicare Coverage Improve Cancer Detection and Mortality Outcomes?, NBER Working Papers (2019) (2019)
- Health technology assessment with risk aversion in health
Journal of Health Economics, 2020, 72, (C) View citations (7)
- The Social Value of Improvement in Activities of Daily Living among the Advanced Parkinson’s Disease Population
Forum for Health Economics & Policy, 2020, 23, (2), 1-23
- Unintended Consequences of Products Liability: Evidence from the Pharmaceutical Market*
(An Economic Analysis of Mary Carter Settlement Agreements)
The Journal of Law, Economics, and Organization, 2020, 36, (3), 598-632 View citations (3)
See also Working Paper Unintended Consequences of Products Liability: Evidence from the Pharmaceutical Market, NBER Working Papers (2014) View citations (3) (2014)
2019
- A Flexible Open-Source Decision Model for Value Assessment of Biologic Treatment for Rheumatoid Arthritis
PharmacoEconomics, 2019, 37, (6), 829-843
- Healing the poor: The influence of patient socioeconomic status on physician supply responses
Journal of Health Economics, 2019, 64, (C), 43-54 View citations (6)
See also Working Paper Healing the Poor: The Influence of Patient Socioeconomic Status on Physician Supply Responses, NBER Working Papers (2016) (2016)
2018
- Economics of the Pharmaceutical Industry
Journal of Economic Literature, 2018, 56, (2), 397-449 View citations (41)
2017
- The insurance value of medical innovation
Journal of Public Economics, 2017, 145, (C), 94-102 View citations (14)
See also Working Paper The Insurance Value of Medical Innovation, NBER Working Papers (2015) View citations (6) (2015)
- The role of imperfect surrogate endpoint information in drug approval and reimbursement decisions
Journal of Health Economics, 2017, 51, (C), 1-12 View citations (2)
2016
- Are Biopharmaceutical Budget Caps Good Public Policy?
The Economists' Voice, 2016, 13, (1), 27-42
- Quantifying Gains in the War on Cancer Due to Improved Treatment and Earlier Detection
Forum for Health Economics & Policy, 2016, 19, (1), 141-156
2015
- Insurers’ Negotiating Leverage and the External Effects of Medicare Part D
The Review of Economics and Statistics, 2015, 97, (2), 314-331 View citations (13)
See also Working Paper Insurers’ Negotiating Leverage and the External Effects of Medicare Part D, Boston University - Department of Economics - Working Papers Series (2011) (2011)
- Public-Private Partnership as a Path to Affordable Healthcare in Emerging Markets
Forum for Health Economics & Policy, 2015, 18, (1), 65-74 View citations (1)
2014
- A Cost-Benefit Analysis of Using Evidence of Effectiveness in Terms of Progression Free Survival in Making Reimbursement Decisions on New Cancer Therapies
Forum for Health Economics & Policy, 2014, 17, (1), 21-52
- Are investments in disease prevention complements? The case of statins and health behaviors
Journal of Health Economics, 2014, 36, (C), 151-163 View citations (15)
- Can Oral Nutritional Supplements Improve Medicare Patient Outcomes in the Hospital?
Forum for Health Economics & Policy, 2014, 17, (2), 131-151
- Patient Outcomes and Cost Effects of Medicaid Formulary Restrictions on Antidepressants
Forum for Health Economics & Policy, 2014, 17, (2), 153-168 View citations (1)
2013
- Health insurance as a two-part pricing contract
Journal of Public Economics, 2013, 102, (C), 1-12 View citations (36)
See also Working Paper Health Insurance as a Two-Part Pricing Contract, NBER Working Papers (2006) View citations (15) (2006)
- Pharmaceutical advertising and Medicare Part D
Journal of Health Economics, 2013, 32, (6), 1356-1367 View citations (22)
- The Value of Diagnostic Testing in Personalized Medicine
Forum for Health Economics & Policy, 2013, 16, (2), S87-S99 View citations (3)
- Want More Value from Prescription Drugs? We Need to Let Prices Rise and Fall
The Economists' Voice, 2013, 10, (1), 39-43
2012
- Catastrophe Bonds, Reinsurance, and the Optimal Collateralization of Risk Transfer
Journal of Risk & Insurance, 2012, 79, (2), 449-476 View citations (20)
See also Working Paper Catastrophe Bonds, Reinsurance, and the Optimal Collateralization of Risk-Transfer, NBER Working Papers (2006) View citations (11) (2006)
- Does Intellectual Property Restrict Output? An Analysis of Pharmaceutical Markets
Journal of Law and Economics, 2012, 55, (1), 151 - 187 View citations (15)
- The value of medical and pharmaceutical interventions for reducing obesity
Journal of Health Economics, 2012, 31, (4), 630-643 View citations (8)
See also Working Paper The Value of Medican and Pharmaceutical Interventions for Reducing Obesity, Cahiers de recherche (2011) (2011)
- The welfare effects of medical malpractice liability
International Review of Law and Economics, 2012, 32, (4), 356-369 View citations (14)
See also Working Paper The Welfare Effects of Medical Malpractice Liability, NBER Working Papers (2009) View citations (7) (2009)
2011
- Differences in health between Americans and Western Europeans: Effects on longevity and public finance
Social Science & Medicine, 2011, 73, (2), 254-263 View citations (12)
2010
- An economic evaluation of the war on cancer
Journal of Health Economics, 2010, 29, (3), 333-346 View citations (23)
See also Working Paper An Economic Evaluation of the War on Cancer, NBER Working Papers (2009) View citations (5) (2009)
- Can the ACA Improve Population Health?
The Economists' Voice, 2010, 7, (5), 5
- Erratum: Valuing health technologies at NICE: recommendations for improved incorporation of treatment value in HTA
Health Economics, 2010, 19, (12), 1510-1510 View citations (5)
- Geographic Variation in Health Care: The Role of Private Markets
Brookings Papers on Economic Activity, 2010, 41, (1 (Spring)), 325-361 View citations (17)
- The Contributions of Improved Therapy and Earlier Detection to Cancer Survival Gains, 1988-2000
Forum for Health Economics & Policy, 2010, 13, (2), 22 View citations (5)
- The Fiscal Consequences of Trends in Population Health
National Tax Journal, 2010, 63, (2), 307-30 View citations (8)
- Valuing health technologies at nice: recommendations for improved incorporation of treatment value in HTA
Health Economics, 2010, 19, (10), 1109-1116 View citations (6)
2009
- Innovation and the welfare effects of public drug insurance
Journal of Public Economics, 2009, 93, (3-4), 541-548 View citations (36)
- The growth of obesity and technological change
Economics & Human Biology, 2009, 7, (3), 283-293 View citations (167)
2007
- HOW DOES HEALTH INSURANCE AFFECT WORKERS’ COMPENSATION FILING?
Economic Inquiry, 2007, 45, (2), 286-303 View citations (15)
- HOW DOES TERRORISM RISK VARY ACROSS SPACE AND TIME? AN ANALYSIS BASED ON THE ISRAELI EXPERIENCE
Defence and Peace Economics, 2007, 18, (2), 113-131 View citations (30)
- Labor Supply and Weight
Journal of Human Resources, 2007, 42, (1) View citations (65)
2006
- Does Medicare benefit the poor?
Journal of Public Economics, 2006, 90, (1-2), 277-292 View citations (34)
- HIV Breakthroughs and Risky Sexual Behavior
The Quarterly Journal of Economics, 2006, 121, (3), 1063-1102 View citations (65)
See also Working Paper HIV Breakthroughs and Risk Sexual Behavior, NBER Working Papers (2004) View citations (17) (2004)
- The Economics of Teacher Quality
Journal of Law and Economics, 2006, 49, (1), 285-329 View citations (22)
- The Labor Market Value of Health Improvements
Forum for Health Economics & Policy, 2006, 9, (2), 23 View citations (3)
- The nonprofit sector and industry performance
Journal of Public Economics, 2006, 90, (8-9), 1681-1698 View citations (116)
2005
- A Theory of Health Disparities and Medical Technology
The B.E. Journal of Economic Analysis & Policy, 2005, 4, (1), 1-30 View citations (24)
- Insurance, self-protection, and the economics of terrorism
Journal of Public Economics, 2005, 89, (9-10), 1891-1905 View citations (34)
See also Working Paper Insurance, Self-Protection, and the Economics of Terrorism, NBER Working Papers (2002) View citations (8) (2002)
- Welfare-Enhancing Technological Change and the Growth of Obesity
American Economic Review, 2005, 95, (2), 253-257 View citations (151)
2004
- Disability Forecasts and Future Medicare Costs
Forum for Health Economics & Policy, 2004, 7, (1), 22 View citations (5)
See also Chapter Disability Forecasts and Future Medicare Costs, NBER Chapters, 2004, 75-94 (2004) View citations (8) (2004)
- Social insurance and the design of innovation incentives
Economics Letters, 2004, 85, (1), 57-61 View citations (45)
2003
- Is nursing home demand affected by the decline in age difference between spouses?
Demographic Research, 2003, 8, (10), 279-304 View citations (6)
2002
- The Rise in Old-Age Longevity and the Market for Long-Term Care
American Economic Review, 2002, 92, (1), 295-306 View citations (52)
See also Working Paper The Rise in Old Age Longevity and the Market for Long-Term Care, Working Papers (1998) (1998)
2001
- Public Financing and the Market for Long-Term Care
Forum for Health Economics & Policy, 2001, 4, (1), 19 
See also Chapter Public Financing and the Market for Long-Term Care, NBER Chapters, 2001, 77-94 (2001) (2001)
Chapters
2012
- Economics of Obesity
Chapter 7 in The Elgar Companion to Health Economics, Second Edition, 2012 
Also in Chapter 7 in The Elgar Companion to Health Economics, 2006 (2006)
2011
- Food Prices and the Dynamics of Body Weight
A chapter in Economic Aspects of Obesity, 2011, pp 65-90 View citations (15)
See also Working Paper Food Prices and the Dynamics of Body Weight, National Bureau of Economic Research, Inc (2009) View citations (30) (2009)
- Intellectual Property, Information Technology, Biomedical Research, and Marketing of Patented Products
Elsevier View citations (1)
2010
- Patents, innovation, and the welfare effects of Medicare Part D
A chapter in Pharmaceutical Markets and Insurance Worldwide, 2010, pp 317-344
2004
- Disability Forecasts and Future Medicare Costs
A chapter in Frontiers in Health Policy Research, Volume 7, 2004, pp 75-94 View citations (8)
See also Journal Article Disability Forecasts and Future Medicare Costs, De Gruyter (2004) View citations (5) (2004)
2001
- Medical Care Output and Productivity in the Nonprofit Sector
A chapter in Medical Care Output and Productivity, 2001, pp 119-140 View citations (2)
- Public Financing and the Market for Long-Term Care
A chapter in Frontiers in Health Policy Research, Volume 4, 2001, pp 77-94 
See also Journal Article Public Financing and the Market for Long-Term Care, De Gruyter (2001) (2001)
|
The links between different versions of a paper are constructed automatically by matching on the titles.
Please contact if a link is incorrect.
Use this form
to add links between versions where the titles do not match.
|